1. Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Issue 3 (13th February 2013) Authors: Patriarca, F.; Medeot, M.; Isola, M.; Battista, M.L.; Sperotto, A.; Pipan, C.; Toffoletti, E.; Dozzo, M.; Michelutti, A.; Gregoraci, G.; Geromin, A.; Cerno, M.; Savignano, C.; Rinaldi, C.; Barbone, F.; Fanin, R. Journal: Transplant infectious disease Issue: Volume 15:Issue 3(2013) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗